A Healthy Healthcare System Needs Less Government Intervention
14 May 2026
Jeremy Nighohossian, Senior Fellow and Economist at the Competitive Enterprise Institute, discusses positive developments in healthcare, including changes in drug development, what the resignation of FDA Commissioner Marty Makary may mean for healthcare policy, and why Certificate of Need (CON) laws impede free market competition and access to care.
0:00 0:00

Related Podcasts

Healthcare Affordability and Access Remain Top Priorities
26 March 2026
Sally Pipes, President and CEO of the Pacific Research Institute, discusses how America’s healthcare system has never been better at keeping patients alive and living longer, types of governmental activities and proposals that disrupt America’s cycle of innovation, and the real drivers of high drug costs in America.
Government Should Not Be Picking Winners and Losers in Healthcare
28 June 2024
Lauren Stewart, Senior Federal Legislative Liaison at Americans for Prosperity and Concerned Veterans for America, discusses how President Biden is attempting to rewrite his record on healthcare, how his policies have resulted in limited access and increased costs for Americans, and how a personal option healthcare plan can provide more choices and more solutions.
Reducing Government Bureaucracy will Reduce Healthcare Costs
10 March 2022
Dr. Diana M. Girnita, MD, PhD, CEO & Founder of Rheumatologist OnCall and a strong advocate for empowering physicians and patients to take charge of their medical health, discusses some of the serious challenges with America's healthcare system, why patients and their physicians should be allowed to assess the risks and make their own decisions free from government mandates, and how health savings accounts (HSAs) can further improve access to healthcare.
Democrats' Social Plan Seeks to Expand Government-Run Healthcare
04 November 2021
In an interview with CFIF, Dr. Kathleen Brown, a dermatologist and health care policy activist, discusses Democrats' social plan, its potential impact on healthcare services to patients, and how it would result in the biggest expansion of government interference in health care in decades.
The Perils of Government-Sponsored Healthcare
14 May 2021
Sally Pipes, President, CEO and Thomas W. Smith Fellow in Healthcare Policy at the Pacific Research Institute, discusses Senator Bernie Sanders' proposal to lower the Medicare eligibility age, the problems with government-sponsored healthcare plans and the various public options and subsidies being considered by some states, and the negative impact on innovation of prescription drug price controls.
Healthcare Scares: ObamaCare, Government Regulations, and Bioterrorism
19 June 2015
Robert King, Healthcare Correspondent for the Washington Examiner, discusses King v. Burwell, ObamaCare's impact on small businesses, prescription drugs and government intervention, and whether America is ready for a bioterror attack.